|
Manuscripts in Portuguese, Spanish and English are accepted.
Manuscripts must be typed and submitted in .doc, .txt or .rtf format, in Arial12 font on A-4 standard size paper, 1.5 line spacing ; left alignment.
The pages should not be numbered.
Title:
a) Full title of the article, in Portuguese or Spanish and in English, including a short title for each page.
Abstract: papers must include an abstract that consists of a minimum of 150 and a maximum of 250 words. In addition to an abstract in English, papers that are submitted in English must have an abstract in Portuguese.
Abstracts of original papers must state the most salient aspects of the objectives, methodology, results and conclusions of the paper. For other types of articles, the format of the abstracts should also be narrative, however they must include the same information. Abstracts should not contain citations.
Keywords: indicate, in the specific field, from three to six terms that identify the study's subject matter using Health Science descriptors - DeCS - from Bireme - available at https://decs.bvsalud.org/
Body of the paper: The total number of words in the article should not exceed 4,000, including Introduction; Method; Result; Discussion; Conclusion and Acknowledgements (the last of which is not compulsory).
Introduction: should contain the purpose and the justification of the study; its importance, scope, limitations, controversies and other information that the author deems relevant. It should be brief, except for manuscripts that are submitted as Review Articles.
Methodology: this section should describe how the sample originated and the sampling process, and present data regarding the research metrics and the analysis strategy that was used. For studies that involve humans, the project must include the use of an Informed Consent Form, which is presented to the study participants upon approval by the Ethics Committee of the institution where the project was undertaken.
Results: results must be presented in a clear, concise manner. Tables and figures must be presented in such a way as to be self-explanatory, and should mention statistical significance, when relevant. One should avoid repeating data that appears in the body of the paper. The maximum number of tables and/or figures is 5 (five).
Discussion: this section should analyze the results, present the authors’ interpretation / evaluation based on observations that appear in current literature and the implications/ramifications that are implicit to knowledge about the subject. The challenges and limitations of the study should be mentioned in this section.
Conclusion: this section should present the conclusions that drawn that are relevant to the project's objective and indicate future directions towards which research could progress.
Acknowledgments: acknowledgments of institutions or individuals that effectively collaborated with the work can be stated in this section in a paragraph of up to five lines.
References: references must be standardized in accordance with the Vancouver style. References in the text, tables and figures must be identified with Arabic numerals that correspond to their respective numbers in the list of references. References must be listed in the order they appear for the first time in the text (not in alphabetical order). Each of the works that are cited in the text must appear in the references.
A minimum of 50% of references should be from publications in the last five years.
The authors are responsible for the accuracy of the references, as well as their proper citation within the body of the paper.
Footnotes: should be limited to those that are absolutely necessary; an end note should not be included.
Images, figures, tables, charts or drawings must be forwarded or produced in Excel or Word format and must be editable and in grayscale or black.
Graphs should use font size 11, be centralized, and include information about the location and year of the event/collection.
Work that is developed using statistical software (such as SPSS, BioStat, Stata, Statistica, R, Mplus etc.) will be accepted, however, it should be edited afterwards in accordance with the requirements of the final normative statement and translated into English.
Studies involving human participants: must include information regarding approval by the ethics committee for research involving humans, in accordance with Resolution No. 466/2012 of the Conselho Nacional de Saúde (National Health Council). The last paragraph of the "Method" section must clearly state compliance with Resolution 466. The manuscript must include a copy of the authorization of the Ethics Committee's normative statement.
Clinical trials: the Revista Brasileira de Geriatria e Gerontologia supports the World Health Organization (WHO) and the International Committee of Medical Journal Editors (ICMJE) policies for the registration of clinical trials and recognizes the importance of these initiatives for the registration and international public disclosure of information regarding clinical studies. As a result, beginning in 2007, the only clinical research papers that will be accepted for publication are those that have received an identification number from one of the Clinical Trial Registries certified in accordance with the criteria established by the ICMJE and WHO, whose e-mail addresses are available on the ICMJE website. The identification number must appear at the end of the abstract.
The author must consult the following Checklists, in accordance with the type of study carried out:
-
CONSORT - for controlled and randomized clinical trials
-
CONSORT CLUSTER - an extension for clinical trials with clusters
-
TREND - nonrandomized evaluation concerning public health
-
STARD - for diagnostic precision tests
-
REMARK - for prognostic precision tests
-
STROBE - for observational epidemiological studies (cohort, case control or cross-sectional study)
-
MOOSE - for meta-analysis of observational epidemiological studies
-
PRISMA - for systematic reviews and meta-analyses
-
CASP - for integrative reviews
-
COREQ – for qualitative studies
Researches with humans subjects: must follow the ethical principles for the medical researches adopted by World Medical Association meeting in Helsinki and the amendments from following meetings (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ ), and current laws from the country in which the research was made. Researches made in Brazil must include the information on the Ethics Committee approval, according to resolutions number 466/ 2012 and 510/ 2016 by National Health Council. In the section of the Methods, the last paragraph must have a sentence assuring its accomplishment. The manuscript must be accompanied by a copy of the approval of the Ethics Committee.
Clinical Trials: BJGG supports the politics on the registration of clinical trials of the World Health Organization (WHO) and of the International Committee of Medical Journal Editors (ICMJE), recognizing the importance of these initiatives to the registration and international presentation of clinical trials information, in open access. Thus, only will be accepted for publication manuscripts on clinical trials which have received an identification number from a Clinical Trials Registration based on criteria established by WHO and ICMJE. The identification number must be cited at the end of the abstract.
Links: http://www.who.int/ictrp/network/primary/en/ and http://www.icmje.org/
|
